What is SMA and Why is it Trending Right Now?
What is SMA and Why is it Trending Right Now?
Published
Tags
Spinal muscular atrophy (SMA) has become increasingly prominent in medical discussions, particularly as around 70 children are born with this rare genetic condition each year in the UK. This neuromuscular disorder is trending not only because of breakthrough treatments but also due to enhanced carrier screening tests that can help prospective parents understand their risks. Understanding SMA is crucial for couples planning a family, as early detection and intervention can significantly impact outcomes.
Understanding Spinal Muscular Atrophy
Spinal muscular atrophy is a genetic neuromuscular disorder that causes certain muscles to become weak and waste away. This condition affects the motor neurones in the spinal cord, which are responsible for controlling voluntary muscle movement. When these nerve cells deteriorate, muscles cannot receive the signals they need to function properly, leading to progressive weakness and atrophy.
SMA is caused by mutations in the SMN1 gene, which produces a protein essential for motor neurone survival. Without sufficient levels of this protein, motor neurones gradually die, resulting in muscle weakness that typically affects the muscles closest to the centre of the body first, including those controlling breathing, swallowing, and movement.
The condition follows an autosomal recessive inheritance pattern, meaning both parents must carry a faulty copy of the gene for their child to develop SMA. Our comprehensive spinal muscular atrophy information provides detailed guidance for families considering genetic screening.
The Five Types of SMA
SMA is classified into five distinct types based on the age of onset and severity of symptoms. Understanding these classifications helps healthcare professionals and families plan appropriate care and set realistic expectations.
- SMA Type 0: The most severe form, with symptoms appearing before birth. Babies are born with severe muscle weakness and breathing difficulties.
- SMA Type 1 (Werdnig-Hoffmann disease): Symptoms appear within the first six months of life. Children typically cannot sit without support and face significant breathing and feeding challenges.
- SMA Type 2: Onset occurs between 6-18 months. Children can sit independently but cannot walk unassisted. Most maintain this ability throughout childhood.
- SMA Type 3 (Kugelberg-Welander disease): Symptoms begin after 18 months of age. Children can walk independently initially but may lose this ability over time.
- SMA Type 4: Adult-onset form with mild symptoms that typically don’t affect life expectancy significantly.
The NHS recognises that early diagnosis is crucial, as new treatments are most effective when started as soon as possible after birth.
Why SMA is Trending in Medical Circles
Several factors have brought SMA to the forefront of medical and public attention in recent years. The development of groundbreaking treatments has transformed what was once considered an untreatable condition into one where early intervention can dramatically improve outcomes.
The introduction of gene therapies and other disease-modifying treatments on the NHS has created renewed hope for families affected by SMA. These treatments work best when administered early, making prenatal and newborn screening increasingly important. The success stories emerging from early treatment programmes have captured media attention and raised public awareness.
Additionally, advances in genetic screening technology have made it easier and more accessible for couples to understand their carrier status. Advanced prenatal screening can now detect SMA risk with greater accuracy than ever before, leading to increased uptake of testing services.
High-profile campaigns by patient advocacy groups and increased research funding have also contributed to SMA’s visibility. The condition has gained attention from celebrities and public figures, further raising awareness about this previously little-known genetic disorder.
Carrier Screening and Inheritance Patterns
Approximately one in 40-50 people in the UK carries a faulty copy of the SMN1 gene, making SMA carrier screening particularly relevant for prospective parents. When both parents are carriers, there is a 25% chance with each pregnancy that their child will have SMA, a 50% chance the child will be a carrier, and a 25% chance the child will be unaffected.
Carrier screening can be performed before conception or during early pregnancy. The test involves a simple blood sample that analyses DNA for mutations in the SMN1 gene. Most carriers have no symptoms and are unaware of their status until testing reveals it.
If both partners are identified as carriers, genetic counselling becomes essential. Our genetic counselling services help couples understand their options, which may include prenatal diagnostic testing, preimplantation genetic testing (PGT), or accepting the natural risk.
The Human Fertilisation and Embryology Authority (HFEA) has approved the use of PGT-M for couples at risk of having a child with SMA Types 1, 2, or 3, providing options for family planning before pregnancy occurs.
Symptoms and Early Warning Signs
Recognising the early signs of SMA is crucial for timely intervention. Symptoms vary depending on the type of SMA, but certain warning signs should prompt immediate medical attention.
- Muscle weakness: Progressive weakness that typically affects muscles closest to the torso first, including shoulders, hips, and back.
- Delayed motor milestones: Late achievement of sitting, standing, or walking compared to typical developmental timelines.
- Breathing difficulties: Weak respiratory muscles can cause breathing problems, particularly during sleep or illness.
- Feeding challenges: Difficulty sucking, swallowing, or maintaining adequate nutrition due to weak facial and throat muscles.
- Tremor: Fine trembling of fingers and hands, particularly noticeable when arms are extended.
- Reduced fetal movement: In severe cases, decreased movement may be noticed during pregnancy.
Parents who notice these symptoms should seek immediate medical evaluation. Early diagnosis allows for prompt treatment initiation, which can significantly improve outcomes and quality of life.
Diagnostic Methods and Testing
Diagnosing SMA involves several approaches, depending on when the condition is suspected. Prenatal diagnosis is possible when both parents are known carriers, whilst postnatal diagnosis typically follows clinical suspicion based on symptoms.
Genetic testing remains the gold standard for SMA diagnosis. A blood sample can reveal deletions or mutations in the SMN1 gene that cause the condition. This testing can be performed prenatally through chorionic villus sampling (CVS) or amniocentesis if both parents are carriers.
Additional diagnostic tools may include electromyography (EMG) to assess muscle and nerve function, muscle biopsy in certain cases, and creatine kinase blood tests. However, genetic testing has largely replaced these more invasive procedures.
The UK National Screening Committee continues to evaluate the potential for newborn screening for SMA, recognising that early detection could improve treatment outcomes. Some regions have begun pilot programmes to assess the feasibility and benefits of population-wide newborn screening.
Treatment Breakthroughs and NHS Availability
The treatment landscape for SMA has been revolutionised in recent years, transforming the outlook for affected children and their families. Three main disease-modifying treatments are now available through the NHS, each working through different mechanisms to address the underlying genetic cause.
Spinraza (nusinersen) was the first approved treatment, administered through spinal injections every four months. This antisense oligonucleotide helps increase production of functional SMN protein from the backup SMN2 gene.
Zolgensma represents a breakthrough in gene therapy, providing a functional copy of the SMN1 gene through a single intravenous infusion. This treatment is most effective when given to babies before symptoms develop or in very early stages of the disease.
Evrysdi (risdiplam) offers an oral treatment option, taken daily as a liquid medicine. This small molecule drug increases SMN protein production and can be used across all SMA types and ages.
The NHS has made these treatments available following NICE approval, recognising their potential to dramatically improve outcomes when started early. Success stories include children who have achieved motor milestones previously thought impossible for their SMA type.
Impact on Family Planning Decisions
The availability of effective treatments has significantly influenced how families approach SMA risk in pregnancy planning. Where previously a positive diagnosis might have led to difficult pregnancy decisions, many families now feel more confident proceeding with pregnancies when SMA is detected.
However, the importance of early detection has never been greater. The most effective outcomes occur when treatment begins before symptoms develop, making prenatal diagnosis and immediate postnatal intervention crucial.
Families with a known risk of SMA have several options to consider. Prepregnancy genetic testing can identify carrier status before conception, allowing couples to make informed decisions about their reproductive choices.
For families who choose to proceed with a pregnancy at risk for SMA, comprehensive prenatal care and planning for immediate postnatal intervention becomes essential. This includes coordination with specialist neuromuscular centres and preparation for early treatment initiation if needed.
The Role of Genetic Counselling
Genetic counselling plays a vital role in helping families navigate SMA-related decisions. Professional genetic counsellors provide essential support in understanding inheritance patterns, risk assessment, and available options for testing and family planning.
During counselling sessions, families learn about the implications of carrier status, the likelihood of having an affected child, and the various testing options available. Counsellors also provide emotional support and help families process complex medical information.
For families with an SMA diagnosis, genetic counselling extends to discussing treatment options, coordinating care with specialist centres, and planning for future pregnancies. The recurrence risk remains 25% for subsequent pregnancies, making ongoing genetic counselling valuable.
Our genetic testing and counselling services provide comprehensive support throughout this process, ensuring families have access to accurate information and emotional support when making these important decisions.
Latest Research and Future Developments
Research into SMA continues to advance rapidly, with several promising developments on the horizon. Scientists are investigating combination therapies that might provide even greater benefits than current single treatments.
Studies are exploring the potential for prenatal treatment, where therapy could begin before birth to prevent symptom development entirely. Early research suggests this approach might offer the best possible outcomes for the most severe forms of SMA.
Improved screening methods are also under development, including more comprehensive carrier screening panels and enhanced newborn screening protocols. These advances could identify more at-risk pregnancies and affected newborns, enabling earlier intervention.
Long-term outcome studies are providing valuable data about the effectiveness of current treatments, helping clinicians optimise treatment protocols and timing. This research is particularly important for understanding how early intervention affects long-term development and quality of life.
How the London Pregnancy Clinic Can Help
The London Pregnancy Clinic offers comprehensive genetic screening and counselling services to support families concerned about SMA and other genetic conditions. Our experienced team provides expert guidance throughout the screening and diagnostic process.
We offer advanced carrier screening tests that can identify SMA carrier status in prospective parents. Our clinical genetics consultations provide detailed risk assessment and counselling for couples considering their family planning options.
For pregnancies identified as being at risk for SMA, we provide specialised prenatal diagnostic services and coordinate care with leading fetal medicine specialists. Our genetic counselling sessions ensure families receive comprehensive support and information to make informed decisions.
We also offer advanced prenatal screening through NIPT and other genetic testing options, helping identify pregnancies that may benefit from further diagnostic testing. Our state-of-the-art facilities and expert sonographers provide detailed ultrasound assessments when indicated.
Final Thoughts
Spinal muscular atrophy represents both a significant challenge and a remarkable success story in modern genetics and medicine. The transformation from an untreatable condition to one where early intervention can dramatically improve outcomes demonstrates the power of scientific advancement and dedicated research.
For prospective parents, understanding SMA and carrier screening options has never been more important. The availability of effective treatments means that early detection and intervention can make a profound difference in a child’s development and quality of life.
If you’re concerned about genetic conditions like SMA or considering carrier screening, our expert team is here to provide guidance and support. Contact the London Pregnancy Clinic to discuss your options and ensure you have access to the latest screening technologies and genetic counselling services.
Sources
- SMA (Spinal Muscular Atrophy): What It Is, Symptoms & Types
- Carrier Screening for Spinal Muscular Atrophy (SMA) | ACOG
- Presentation: Pregnancy at risk of spinal muscular atrophy — In the Clinic
- Family Planning For Couples Affected By 5q SMA – SMAUK
- Prenatal Management of Spinal Muscular Atrophy in the Era of Genetic Screening and Emerging Opportunities in In Utero Therapy – PMC
- Spinal muscular atrophy (SMA) – NHS
- Spinal muscular atrophy – UK National Screening Committee (UK NSC) – GOV.UK
- NHS England » New NHS treatments helping extend survival for babies with rare muscle-wasting disease
- Spinal muscular atrophy (SMA) | Great Ormond Street Hospital
- Spinal muscular atrophy type 1: NCARDRS report – NDRS
- Spinal muscular atrophy (SMA) – Muscular Dystrophy UK
- Spinal Muscular Atrophy (SMA) | Nemours KidsHealth
Latest Stories
KNOVA NIPT: London Pregnancy Clinic Pioneers Advanced Genetic Screening in the UK
KNOVA NIPT: London Pregnancy Clinic Pioneers Advanced Genetic Screening in the UK
Published
Tags
The London Pregnancy Clinic stands as the pioneering force behind introducing KNOVA NIPT to the United Kingdom, establishing ourselves as the country’s leading authority in this revolutionary genetic screening technology. With hundreds of successful KNOVA NIPT procedures completed, our clinical team possesses unparalleled expertise that no other UK clinic can match, offering expectant parents the most advanced non-invasive prenatal testing available today.
What is KNOVA NIPT?
KNOVA NIPT (Non-Invasive Prenatal Testing) represents the cutting-edge of genetic screening technology, developed by Fulgent Genetics to provide comprehensive chromosomal analysis from a simple maternal blood sample. Unlike traditional screening methods, KNOVA NIPT can detect a wide range of genetic conditions with exceptional accuracy, typically achieving over 99% detection rates for common trisomies including Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and Patau syndrome (Trisomy 13).
This revolutionary test analyses cell-free foetal DNA circulating in the mother’s bloodstream, eliminating the need for invasive procedures such as amniocentesis or chorionic villus sampling. The technology behind KNOVA NIPT utilises advanced sequencing techniques to examine chromosomal abnormalities, microdeletions, and other genetic variations that could impact your baby’s health and development.
What sets KNOVA NIPT apart from other screening options is its comprehensive scope, capable of detecting up to 100 different chromosomal and genetic conditions. This extensive coverage provides expectant parents with detailed insights into their baby’s genetic profile, enabling informed decision-making throughout their pregnancy journey.
London Pregnancy Clinic: The UK’s KNOVA NIPT Pioneers
The London Pregnancy Clinic holds the distinguished position of being the first healthcare provider to introduce KNOVA NIPT to the United Kingdom. Our pioneering status isn’t merely historical; it represents years of dedicated research, clinical validation, and continuous refinement of testing protocols to ensure optimal outcomes for our patients.
Having performed hundreds of KNOVA NIPT procedures, our clinical team has accumulated invaluable expertise that extends far beyond simple test administration. We understand the nuances of patient counselling, the intricacies of result interpretation, and the importance of providing comprehensive support throughout the testing process. This depth of experience enables us to guide expectant parents through every aspect of their genetic screening journey with confidence and compassion.
Our pioneering work with KNOVA NIPT has established protocols and best practices that other clinics across the UK now follow. We continue to collaborate with Fulgent Genetics to advance the technology further, ensuring our patients always receive the most current and comprehensive genetic screening available. This commitment to innovation and excellence has made us the preferred choice for healthcare professionals and expectant parents seeking the highest standard of prenatal genetic testing.
The Science Behind KNOVA NIPT Excellence
KNOVA NIPT employs sophisticated next-generation sequencing (NGS) technology to analyse cell-free foetal DNA with remarkable precision. During pregnancy, small fragments of the baby’s DNA circulate in the mother’s bloodstream, typically comprising 3-13% of the total circulating DNA. Our laboratory partners utilise advanced bioinformatics algorithms to distinguish between maternal and foetal DNA sequences, enabling accurate detection of chromosomal abnormalities.
The test’s exceptional accuracy stems from its ability to analyse millions of DNA fragments simultaneously, creating a comprehensive genetic profile that traditional screening methods cannot achieve. This technological advancement allows KNOVA NIPT to detect not only common trisomies but also rare chromosomal conditions and microdeletions that affect fewer than 1 in 1000 pregnancies.
Our expertise in KNOVA NIPT extends to understanding the technical limitations and optimal timing for testing. We recommend performing the test after 9 weeks of pregnancy when foetal DNA levels are sufficient for accurate analysis. Our experienced phlebotomists ensure proper sample collection and handling, whilst our clinical team provides thorough pre-test counselling to ensure patients understand the scope and limitations of the screening.
Comprehensive Genetic Conditions Detected
KNOVA NIPT’s comprehensive screening capability encompasses a broad spectrum of genetic conditions, making it the most thorough non-invasive prenatal test available in the UK. The test categorises conditions into several key areas, each providing crucial information about your baby’s genetic health.
- Common Trisomies: Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and Patau syndrome (Trisomy 13) with over 99% detection accuracy.
- Sex Chromosome Abnormalities: Turner syndrome, Klinefelter syndrome, Triple X syndrome, and XYY syndrome affecting sexual development and fertility.
- Rare Trisomies: Additional chromosomal duplications including Trisomies 9, 16, and 22 that can impact foetal development.
- Microdeletions: Small chromosomal deletions including 22q11.2 deletion syndrome (DiGeorge syndrome), Prader-Willi syndrome, and Angelman syndrome.
- Copy Number Variants: Chromosomal duplications and deletions that may affect intellectual development and physical characteristics.
Our extensive experience with KNOVA NIPT enables us to provide detailed counselling about each condition, helping parents understand the implications of positive results and the importance of confirmatory testing when necessary.
The KNOVA NIPT Testing Process
Our streamlined KNOVA NIPT process reflects years of refinement based on hundreds of successful procedures. The journey begins with a comprehensive consultation where our specialist team discusses your medical history, family background, and specific concerns about genetic conditions. This personalised approach ensures that KNOVA NIPT is appropriate for your individual circumstances.
The testing procedure itself is remarkably straightforward, requiring only a simple blood draw from the expectant mother. Our experienced phlebotomists ensure comfortable sample collection using specialised tubes designed to preserve cell-free DNA integrity. We combine this blood test with a detailed pregnancy assessment including ultrasound scanning to confirm gestational age and foetal viability.
Sample processing occurs in Fulgent Genetics’ state-of-the-art laboratories, where advanced sequencing technology analyses the genetic material. Results are typically available within 7-10 working days, after which our clinical team schedules a comprehensive results consultation to discuss findings, answer questions, and provide ongoing support as needed.
Clinical Advantages of Our Expertise
Our position as the UK’s KNOVA NIPT pioneers translates into tangible clinical advantages for our patients. Having performed hundreds of these tests, we have developed sophisticated protocols for managing complex cases, including multiple pregnancies, previous pregnancy complications, and patients with specific risk factors that may affect test accuracy.
Our clinical team’s extensive experience enables us to identify cases where KNOVA NIPT may provide inconclusive results, such as maternal mosaicism or confined placental mosaicism. We have established clear pathways for managing these situations, including repeat testing protocols and alternative screening strategies when appropriate.
Furthermore, our expertise extends to post-test management, including coordination with specialist genetic counsellors, foetal medicine specialists, and other healthcare providers when positive results require further investigation. We maintain strong relationships with leading UK genetic centres, ensuring seamless referral pathways for confirmatory testing and ongoing care.
Integration with the SMART Test Programme
KNOVA NIPT forms the cornerstone of our innovative SMART Test programme, which combines advanced genetic screening with detailed ultrasound assessment. This comprehensive approach, developed exclusively at the London Pregnancy Clinic, provides the most thorough evaluation of foetal health available in the UK.
The SMART Test KNOVA package includes two expert foetal scans alongside the genetic screening, creating a dual approach that maximises detection of both genetic and structural abnormalities. Our specialist sonographers perform detailed anatomical surveys whilst the KNOVA NIPT analyses chromosomal integrity, providing complementary information that enhances overall screening accuracy.
This integrated approach reflects our understanding that genetic conditions often have physical manifestations that can be detected through expert ultrasound examination. By combining these modalities, we can provide expectant parents with the most comprehensive assessment of their baby’s health, backed by our unparalleled expertise in both genetic screening and prenatal imaging.
Accuracy and Reliability
KNOVA NIPT demonstrates exceptional accuracy rates that have been validated through our extensive clinical experience. For common trisomies, the test achieves sensitivity rates exceeding 99%, with false positive rates remaining below 0.1%. These performance metrics represent real-world outcomes from our hundreds of completed tests, providing robust evidence of the technology’s clinical reliability.
Our experience has enabled us to identify factors that may influence test reliability such as medical history and genetic conditions. We use this knowledge to optimise testing protocols and provide patients with realistic expectations about test performance in their specific circumstances.
It’s important to understand that KNOVA NIPT is a screening test, not a diagnostic procedure. Positive results require confirmatory testing through amniocentesis or chorionic villus sampling. Our extensive experience includes managing the emotional and clinical aspects of positive results, ensuring patients receive appropriate support and timely access to confirmatory procedures when needed.
Patient Experience and Support
Our pioneering experience with KNOVA NIPT has taught us that technical excellence must be matched with exceptional patient care. We understand that genetic screening can provoke anxiety and uncertainty, which is why we have developed comprehensive support protocols that address both the clinical and emotional aspects of prenatal testing.
From initial consultation through results delivery, our patients benefit from continuous access to specialist support. We provide detailed pre-test counselling that explains the scope of conditions tested, the meaning of results, and the implications for pregnancy management. This educational approach empowers patients to make informed decisions about their genetic screening options.
Our post-test support includes detailed results consultations, access to genetic counselling services, and coordination with other specialists when additional care is required. We maintain long-term relationships with our patients, providing ongoing support throughout pregnancy and beyond when genetic conditions are identified.
Comparing KNOVA NIPT to Other Tests
Our extensive experience with multiple NIPT platforms positions us uniquely to advise patients about the advantages of KNOVA NIPT compared to alternative screening options. Unlike more limited tests that screen for only common trisomies, KNOVA NIPT provides comprehensive analysis of up to 100 genetic conditions, offering unparalleled screening breadth.
Traditional NHS screening programmes, whilst valuable, cannot match the scope and accuracy of KNOVA NIPT. The combined first trimester screening offered through the NHS detects approximately 85% of Down syndrome cases, compared to KNOVA NIPT’s >99% detection rate. Additionally, NHS screening cannot detect the rare genetic conditions and microdeletions that KNOVA NIPT identifies.
When compared to other private NIPT options, KNOVA NIPT’s comprehensive panel and advanced technology provide superior clinical value. Our experience demonstrates that patients increasingly prefer comprehensive screening that can detect rare conditions, particularly when family history or other risk factors suggest increased genetic risk.
How the London Pregnancy Clinic Can Help
As the UK’s pioneering KNOVA NIPT provider, the London Pregnancy Clinic offers unmatched expertise in advanced prenatal genetic screening. Our specialist team combines extensive clinical experience with state-of-the-art technology to provide the most comprehensive genetic assessment available to expectant parents.
We offer flexible appointment scheduling at our modern clinic locations, with same-day results consultations available when needed. Our integrated approach combines KNOVA NIPT with expert ultrasound assessment, providing comprehensive evaluation of both genetic and structural foetal development.
Our commitment to excellence extends beyond testing to include comprehensive patient support, detailed counselling services, and seamless coordination with other specialists when additional care is required. We maintain the highest standards of clinical governance whilst providing the personalised care that makes genetic screening as comfortable and informative as possible.
For expectant parents seeking the most advanced genetic screening available, combined with unparalleled clinical expertise, the London Pregnancy Clinic represents the gold standard in UK prenatal care. Our pioneering work with KNOVA NIPT continues to set new benchmarks for genetic screening excellence.
Final Thoughts
The London Pregnancy Clinic’s pioneering role in introducing KNOVA NIPT to the UK reflects our unwavering commitment to advancing prenatal care through innovative technology and clinical excellence. Our extensive experience with hundreds of successful procedures has established us as the nation’s leading authority in comprehensive genetic screening.
For expectant parents seeking the most advanced genetic screening available, KNOVA NIPT offers unparalleled insight into their baby’s genetic health. Combined with our expert clinical team’s guidance and support, this technology provides the foundation for informed decision-making throughout pregnancy.
If you’re considering genetic screening during pregnancy, we invite you to benefit from our pioneering expertise and comprehensive approach to prenatal care. Contact the London Pregnancy Clinic today to schedule your consultation and discover how our KNOVA NIPT experience can provide you with the confidence and reassurance you deserve during this important time.
Latest Stories
Pre Eclampsia Awareness
Pre-Eclampsia Awareness Month
What is Pre-Eclampsia and innovations in the field?
-
Published
-
Last Modified
Tags
Pre-eclampsia is a serious hypertensive disorder affecting pregnant women, usually developing after 20 weeks of gestation or in the postpartum period. Characterised by high blood pressure, it can lead to severe complications if not managed properly. This blog raises pre-eclampsia awareness, including its symptoms, statistics, management strategies, and the services offered by the London Pregnancy Clinic.
LPC is joining the efforts to raise awareness about pre-eclampsia and support ongoing research to improve outcomes for mothers and babies worldwide. May is National Pre-Eclampsia Awareness Month, and we partner with the Pre-Eclampsia Foundation to ensure every mother knows the signs and symptoms of pre-eclampsia. Share the message and join the campaign to make a difference.
What is Pre-eclampsia
It is a condition characterised by persistent high blood pressure that arises during pregnancy or shortly after childbirth. It typically develops after the 20th week of pregnancy or within six weeks postpartum. This disorder can have significant implications for both the mother and the baby, making early detection and careful management crucial.
Statitstics
Hypertensive disorders of pregnancy (HDPs) affect 5-10% of all pregnancies worldwide, including conditions like pre-eclampsia, eclampsia, HELLP syndrome (haemolysis, elevated liver enzymes, low platelets), and gestational hypertension. These disorders are a leading cause of maternal and infant mortality globally. Annually, pre-eclampsia results in approximately 76,000 maternal deaths and 500,000 infant deaths worldwide.
The United States ranks 47th in the world for maternal mortality, with a rising rate unlike other industrialised nations. HDPs, including pre-eclampsia, are significant contributors to maternal and infant illness and death in the US. Black women face a disproportionately higher risk, experiencing severe maternal morbidity events at a rate 2.1 times greater than white women. Despite these grave statistics, about 60% of maternal deaths due to pre-eclampsia are preventable with proper medical care and timely intervention.
Symptoms
Recognising the symptoms of pre-eclampsia early can significantly improve outcomes. Common symptoms include:
- Severe headaches
- Swelling in the hands and face
- Visual disturbances
- Nausea and vomiting
- Stomach or abdominal pain
- Sudden weight gain
- Shortness of breath
If you experience any of these symptoms, it is crucial to seek medical attention immediately. Pre-eclampsia can escalate quickly, and early intervention is vital for the health of both the mother and the baby.
Pre-eclampsia Management
This conition requires careful management to ensure a healthy pregnancy outcome. The condition can develop from 20 weeks of pregnancy up to six weeks after childbirth. High blood pressure is typically controlled with antihypertensive medications. Additionally, maintaining a healthy lifestyle can help reduce the risk of developing pre-eclampsia. This includes:
- Regular prenatal check-ups
- Monitoring blood pressure regularly
- Eating a balanced diet rich in fruits, vegetables, and whole grains
- Engaging in regular physical activity
- Avoiding smoking and limiting alcohol consumption
Implementing easy-to-understand educational tools for patients about pre-eclampsia signs and symptoms is crucial. Screening for risk factors, considering aspirin use during the first trimester, and early hypertension control can also help decrease rates of pre-eclampsia. Hospitals should standardise care guidelines for managing hypertensive disorders of pregnancy to decrease maternal illness and death. Supporting perinatal quality collaboratives can help hospitals reduce early delivery and severe pregnancy complications.
It is essential to consult with a healthcare professional before making any lifestyle changes or starting new medications.
Raising Pre-eclampsia Awareness
The LPC is joining the efforts to raise awareness about pre-eclampsia and support ongoing research to improve outcomes for mothers and babies worldwide. May is National Pre-Eclampsia Awareness Month, and we partner with the Pre-Eclampsia Foundation to ensure every mother knows the signs and symptoms of pre-eclampsia. Share the message and join the campaign to make a difference.
If you need more information about pre-eclampsia, please visit the Pre-Eclampsia Foundation. Together, we can help prevent pre-eclampsia and ensure better health for future generations.
Pre-eclampsia Tests During Pregnancy
During pregnancy, your healthcare provider checks your blood pressure at each prenatal visit. This is essential to ensure it remains within a safe range. They also test your urine for protein, which indicates kidney health. If protein is found, you might need to collect urine over 24 hours to measure protein levels accurately.
Blood Pressure Monitoring
Your healthcare provider measures your blood pressure at every prenatal appointment. This should be done after you’ve been sitting comfortably for a few minutes. The cuff is placed on your upper bare arm at heart level. High blood pressure is traditionally defined as 140/90 or greater, measured on two separate occasions six hours apart. Severe high blood pressure (160/110 or greater) needs immediate treatment.
Urine Tests
At each prenatal appointment, you provide a urine sample. Healthy kidneys don’t allow significant protein into the urine. If protein is detected, further testing might be required. Your provider might ask you to collect all your urine in a jug for 24 hours to measure protein levels. Alternatively, a “spot check” compares protein to creatinine levels to gauge kidney health.
Blood Tests
These are crucial for diagnosing pre-eclampsia. They include a complete blood count (CBC) with platelet count and assessment of liver enzymes and creatinine levels. These tests provide a baseline for monitoring your health. If you show symptoms of severe pre-eclampsia, your provider will order additional blood tests.
Monitoring Your Baby
Your provider may schedule more frequent ultrasounds or non-stress tests (NST) to monitor your baby’s growth and blood flow through the umbilical cord and placenta. Continuous fetal monitoring might be necessary if symptoms appear rapidly.
Pre-eclampsia Tests Post Partum
Pre-eclampsia can develop up to six weeks postpartum. Symptoms include severe headache, vision changes, and difficulty breathing. It’s crucial to report these symptoms to your provider immediately. Blood pressure checks are recommended three and ten days after delivery to monitor any changes.
After Pregnancy
Post-pregnancy, additional tests might uncover underlying conditions contributing to pre-eclampsia. These include tests for autoimmune conditions, blood clotting disorders, and kidney function. Your healthcare provider will monitor your health and recommend necessary treatments.
Long-Term Care
Women with a history of pre-eclampsia are at higher risk of heart disease, stroke, diabetes, and chronic high blood pressure later in life. Annual monitoring of your weight, blood pressure, blood sugar, and cholesterol is crucial for maintaining long-term health.
Pre-eclampsia testing can seem overwhelming, but understanding these tests helps you stay informed and proactive about your health. Always discuss any concerns with your healthcare provider to ensure you receive the best possible care.
What We Offer for Pre-eclampsia
At LPC, we provide specialised care for pregnancies affected by pre-eclampsia. Our Consultant Obstetrician, Mr Daniel Stott, has extensive experience in managing pre-eclampsia and offers comprehensive post-natal care. He also runs a dedicated pre-eclampsia clinic at University College London Hospitals NHS Foundation Trust. Mr Stott has published extensively on hypertensive pregnancies and is committed to supporting mothers throughout their pregnancy journey.
Learn more about our private obstetric services on our dedicated page. We aim to provide personalised care and address any concerns you may have during or after pregnancy. We also offer private midwifery services to help you deal with pre-eclampsia:
- Monitoring: Midwives closely monitor pregnant women and their fetuses for signs of pre-eclampsia during routine antenatal appointments by checking blood pressure and urine samples. Midwives also act on signs of deterioration.
- Advising: Midwives advise women and their partners without frightening them, and interpret doctor’s information when necessary.
- Other responsibilities: Midwives may arrange a visit to the special care baby unit if appropriate, and provide continuity of midwifery care.
Final Thoughts
Pre-eclampsia is a significant concern in maternal health, but with early detection and proper management, most pregnancies can have positive outcomes. The LPC is dedicated to providing expert care and support for expectant mothers dealing with pre-eclampsia. We encourage you to reach out to us for more information or to schedule a consultation.
If you need more information about pre-eclampsia, please visit the Pre-Eclampsia Foundation. Together, we can help prevent pre-eclampsia and ensure better health for future generations.
Latest Stories
Women’s Health Awareness Month
Maternal Mental Health Awareness
Discover the importance of Maternal Mental Health in 2024.
-
Published
-
Last Modified
Tags
May is Women’s Health Month, a time to prioritise and celebrate women’s health, beginning with National Women’s Health Week. This blog post highlights the importance of women’s health, with a particular focus on pregnancy, fertility, and gynaecology. We’ll discuss key health concerns, preventive measures, and the importance of regular checkups to ensure women’s well-being during different stages of life.
During the month of May, as flowers bloom and the weather warms up, we celebrate Mother’s Day and recognize Women’s Health Month. As we come to the end of this month-long observance, which kicked off each year on Mother’s Day, emphasises the importance of health and well-being for women across the nation. At the LPC, we focus on providing comprehensive care in pregnancy, fertility, and gynaecology, ensuring women have access to the information and medical support they need.
Urgent Support
If you find yourself in crisis, feeling despair, or experiencing suicidal thoughts, it’s crucial to seek help immediately. Reach out to a healthcare professional—this could be your GP, midwife, or health visitor.
Alternatively, you can take the following steps:
- Locate your closest NHS urgent mental health helpline (available in England only).
- Contact the Samaritans by calling 116 123.
Remember, you are not alone. Mental health issues during and after pregnancy are common, and support is readily available.
What is Women’s Health Awareness?
Women’s Health Awareness is a dedicated effort to educate and empower women about their health and well-being. It focuses on highlighting the unique health challenges women face and provides essential information on prevention, early detection, and treatment. This awareness is vital in promoting healthier lifestyles and improving health outcomes for women of all ages.
According to the UK’s First Women’s Health Strategy for England, addressing the gender health gap is crucial. Women live longer than men on average but spend more of their lives in poor health, often limiting their ability to work and participate in day-to-day activities. Closing this health gap and supporting women to live well will benefit not only their health and wellbeing but also the economy.
Women’s Health Awareness encourages women to take control of their health by staying informed about various health issues. It emphasises the importance of regular health screenings, vaccinations, and checkups. These preventive measures are crucial for detecting potential health problems early, ensuring timely treatment, and improving prognosis.
Responses to the call for evidence highlighted a need for greater focus on women-specific health conditions, including fertility and pregnancy loss, and gynaecological conditions such as endometriosis, which affects 1 in 10 women.
Lifestyle factors play a significant role in women’s health. Women’s Health Awareness promotes healthy habits, including balanced nutrition, regular physical activity, and avoiding harmful behaviours like smoking and excessive alcohol consumption. Adopting a healthy lifestyle is fundamental to preventing many health issues.
The Importance of Women’s Health Awareness Month?
Women’s Health Month serves as a vital reminder for women to prioritise their health. Taking care of your health is essential, and this month encourages you to focus on your well-being. Start by scheduling necessary medical appointments. Regular checkups, examinations, and vaccinations play a crucial role in maintaining good health. Preventive care helps detect potential issues early, ensuring timely treatment.
Adopting a healthy lifestyle is another key aspect of Women’s Health Month. Incorporate balanced nutrition, regular exercise, and sufficient sleep into your daily routine. A healthy diet rich in fruits, vegetables, and whole grains supports overall well-being. Regular physical activity helps maintain a healthy weight and reduces the risk of chronic diseases. Aim for at least 30 minutes of moderate exercise daily.
Mental health is equally important. Take time to manage stress, practice mindfulness, and seek support when needed. Engaging in activities that bring joy and relaxation can significantly improve mental well-being. Remember, mental health impacts physical health, so it’s essential to address any concerns promptly.
Women’s Health Month also highlights the importance of understanding your body and recognising potential health risks. Stay informed about common health issues affecting women, such as breast cancer, cervical cancer, and cardiovascular disease. Knowing the symptoms and risk factors enables you to take preventive measures and seek medical advice early.
Given that around 15% of women over 18 report being in poor health, raising awareness is crucial. This month encourages women to take proactive steps towards better health. Share information with friends and family, and support each other in making healthier choices. Together, we can create a community of empowered, health-conscious women.
Key Health Concerns for Women:
One key aspect of Women’s Health Awareness is education about reproductive health. This includes information on menstrual health, contraception, pregnancy, and menopause. Understanding these aspects of health enables women to make informed decisions about their bodies and well-being.
While these issues are connected to reproductive health, they are not solely about pregnancy. Addressing these health concerns is vital for maintaining a high quality of life and ensuring overall health. Here are some of the key health concerns that women should be aware of:
- Breast Cancer: is the second most common cancer among women in the UK. Early detection through regular breast examinations and mammograms is crucial. Women should be aware of the symptoms, such as lumps, changes in breast shape, and skin dimpling, and consult their healthcare provider if they notice any unusual changes.
- Cervical Cancer: affects thousands of women annually, often linked to the human papillomavirus (HPV). Regular Pap smears and HPV vaccinations are effective preventive measures. Recognising symptoms like unusual bleeding and pelvic pain can lead to early diagnosis and better outcomes.
- Ovarian Cancer: is another significant health concern, with risk factors including age and family history. Regular pelvic examinations and being alert to symptoms like bloating, pelvic pain, and changes in urinary habits can aid in early detection.
- Sexual and Reproductive Health: Maintaining sexual and reproductive health is essential for overall well-being. Safe sex practices, STI screenings, and regular checkups help prevent and manage health issues. For those considering pregnancy, preconception health and prenatal care are vital for a healthy pregnancy and baby.
- Physical Activity: Regular physical activity is essential for preventing conditions such as obesity, cardiovascular diseases, and osteoporosis. Women should aim for at least 30 minutes of moderate exercise daily, which can include activities like brisk walking, cycling, or yoga.
- Diet and Nutrition: A balanced diet rich in fruits, vegetables, whole grains, and lean proteins supports overall health. Nutrients such as calcium and vitamin D are particularly important for bone health, helping to prevent osteoporosis.
- Osteoporosis: a condition characterised by weakened bones, is more common in women, especially post-menopause. Adequate calcium and vitamin D intake, along with regular weight-bearing exercises, can help maintain bone density and prevent fractures.
- Cardiovascular Disease: is the leading cause of death among women. Risk factors include diabetes, high blood pressure, and smoking. Regular cardiovascular checkups, a healthy diet, and an active lifestyle are key preventive measures.
Women’s Health Awareness: Preventive Care.
Preventive care, including vaccinations, screenings, and routine checkups, is essential for early detection and management of health issues. Women should adhere to recommended schedules for mammograms, Pap smears, and bone density tests. These regular checkups can detect potential health issues before they become serious, ensuring timely treatment and better outcomes.
Mammograms are vital for early detection of breast cancer. Women should begin regular mammograms at age 40, or earlier if they have a family history of breast cancer. Detecting breast cancer early increases the chances of successful treatment and can save lives.
Pap smears are crucial for detecting cervical cancer. Women should start getting Pap smears at age 25 and continue every three years. If you have a higher risk, your doctor may recommend more frequent screenings. HPV vaccinations also play a key role in preventing cervical cancer.
Routine checkups are also an opportunity to discuss other vaccinations, such as flu shots and the COVID-19 vaccine, which help protect against infectious diseases. Keeping vaccinations up to date is crucial for overall health and preventing outbreaks.
Preventive care extends beyond these screenings. Regular blood pressure checks, cholesterol tests, and diabetes screenings are essential for detecting cardiovascular and metabolic conditions early. Maintaining a healthy lifestyle, including a balanced diet and regular exercise, complements preventive care and boosts overall health. By prioritising preventive care, women can take proactive steps to maintain their health and well-being. Early detection through regular screenings and checkups allows for timely intervention, improving health outcomes and quality of life
Mental Health During Reproductive care.
Mental health care should be an integral part of reproductive care. Women should feel empowered to seek help and support throughout their reproductive journey. By prioritising mental health, women can ensure better outcomes for themselves and their families.
Gynaecological health plays a significant role in mental well-being. Regular gynae checkups, screenings, and open communication with healthcare providers are essential. Addressing gynaecological issues promptly can prevent them from affecting mental health. Conditions like polycystic ovary syndrome (PCOS) or endometriosis can have both physical and emotional impacts.
During preconception, mental health is just as important as physical health. According to a study published in NLM, 1 in 8 couples have trouble getting pregnant. This can impact the mental health concerns of women planning to conceive. Stress, anxiety, or unresolved mental health issues can affect fertility and overall well-being. Consulting a healthcare provider for mental health support during this phase is crucial. Therapy, stress management techniques, and a strong support system can help in preparing for a healthy pregnancy.
Pregnancy is a profound life event that sparks various emotional responses, which affect Maternal Mental Health. Although often joyous, it can also trigger mental health issues such as anxiety and depression. Hormonal changes, past mental health issues, and the stress of impending parenthood all contribute. Recognising symptoms early and seeking support through therapy, support groups, or medical intervention can improve outcomes for both mother and baby.
The postpartum period is a critical time for mental health. Issues such as postpartum depression (PPD) which 1 in 5 women struggle with, anxiety, and psychosis can severely impact a mother’s ability to bond with her child and function daily. Stigma and a lack of awareness often prevent mothers from seeking necessary help. Informing new mothers and their families about the symptoms and available treatments is essential.
Final Thoughts
Women’s Health Awareness Month is a perfect time to prioritise health, educate yourself on potential risks, and take preventive measures. At LPC, we offer comprehensive services, from fertility consultations to prenatal and gynaecological care, tailored to support your health journey. Schedule your preventive care appointments today and take proactive steps toward a healthier, happier life.
Prioritise your health this Women’s Health Month. Take charge of your well-being and embrace a healthier, happier lifestyle. For more information on maintaining good health during pregnancy, visit the NHS’s Keeping Well during Pregnancy page. If you think a referral might help, please speak to your midwife, Women’s Health specialists, GP or health visitor.
-
“We are here today to celebrate Women’s Health Awareness Month. We all know how important it is to make sure that we as women are taken care of through our whole life this can be during before or after pregnancy as well especially when we need a bit of more attention.”
– Ms Shaz Khojasteh
Latest Stories
Maternal Mental Health Awareness
Maternal Mental Health Awareness
Discover the importance of Maternal Mental Health in 2024.
-
Published
-
Last Modified
Tags
Maternal Mental Health Awareness Week casts a spotlight on the crucial mental health challenges mothers encounter both during and after pregnancy. This post delves into these issues, offering strategies for personal care and emphasising employer support for the well-being of returning mothers.
Maternal mental health often gets overlooked, with the focus shifting to physical health and newborn care. However, the mental well-being of mothers is just as critical and warrants equal attention and support. In many countries, around 1 in 5 new mothers experience a mood or anxiety disorder that goes unnoticed and untreated due to lack of awareness and stigma. This Maternal Mental Health Awareness Week, we’re exploring significant mental health challenges during pregnancy, after childbirth, and the transition back to work, providing insights and solutions to support mothers in these crucial times.
Urgent Support
If you find yourself in crisis, feeling despair, or experiencing suicidal thoughts, it’s crucial to seek help immediately. Reach out to a healthcare professional—this could be your GP, midwife, or health visitor.
Alternatively, you can take the following steps:
- Locate your closest NHS urgent mental health helpline (available in England only).
- Contact the Samaritans by calling 116 123.
Remember, you are not alone. Mental health issues during and after pregnancy are common, and support is readily available.
What is Maternal Mental Health Awareness Week?
Maternal Mental Health Awareness Week is an annual campaign aimed at raising both public and corporate awareness about the mental health challenges mothers face. It calls for improved care and support for women tackling mental health challenges from the prenatal period through to postpartum and beyond. This week underlines the importance of understanding, recognising, and addressing maternal mental health issues to enhance health outcomes for mothers and their children.
The Maternal Mental Health Alliance (MMHA), a UK charity network comprising over 125 organisations, commits to high-quality care for families facing perinatal mental health issues. This year, the MMHA has set daily themes to enhance the dialogue about maternal mental health. Starting on Monday, 29 April, the focus is on demystifying perinatal mental illness with various resources, including an animation and expert videos. On Tuesday, attention shifts to the support required for perinatal mental health in workplaces.
World Maternal Mental Health Day on Wednesday calls for united advocacy for maternal mental health needs. Thursday explores identity changes during the perinatal period, coinciding with the launch of a new campaign in collaboration with Aveeno Baby. The week progresses with themes that highlight recovery stories, provide empowering resources, and conclude with reflections on Sunday, 5 May. Each theme aims to educate, support, and empower individuals across the UK, promoting a deeper understanding and better support systems for maternal mental health.
Mental Health During Pregnancy
Pregnancy is a profound life event that sparks various emotional responses. Although often joyous, it can also worsen or trigger mental health issues such as anxiety and depression. Factors like hormonal changes, previous mental health issues, and the stress of impending parenthood can all contribute. Early recognition of symptoms and seeking support through therapy, support groups, or medical intervention can mitigate these effects and improve health for both mother and baby.
Mental Health Postpartum
The importance of postpartum mental health cannot be overstated, yet it often receives insufficient attention. Issues such as postpartum depression (PPD), anxiety, and psychosis can severely affect a mother’s ability to bond with her child and function daily. Stigma and a lack of awareness often prevent mothers from seeking necessary help. Informing new mothers and their families about the symptoms and available treatments is essential.
Maternal Mental Health Study
Suicide is a significant cause of maternal death during pregnancy and the year following birth, known as the perinatal period. Despite its rarity in the UK, with a prevalence of 3.84 per 100,000 live births, the consequences of maternal suicide are devastating and enduring. Alarmingly, the estimated global prevalence of suicide attempts is much higher, at 680 per 100,000 during pregnancy and 210 per 100,000 post-birth.
The ASPEN-study, focusing on perinatal suicide attempts, aims to deepen our understanding of the experiences and contexts of these events. This qualitative research highlights the critical need to explore the motives and circumstances leading to suicide attempts among pregnant individuals and new mothers.
The findings suggest that feelings of entrapment and despair, often amidst traumatic life events and adversities, are potential indicators of risk. Recognising these signs early through meaningful enquiry could enhance care, aiding in the timely prevention of maternal suicides and improving overall maternal mental health outcomes.
How Companies Can Help:
Employers play a pivotal role in supporting the mental health of mothers returning to work. Here are effective ways companies can assist:
- Flexible Work Arrangements: Facilitate flexible hours and remote work opportunities to help mothers balance work and home life effortlessly.
- Parental Leave Policies: Develop or enhance parental leave policies that provide sufficient time off for both mothers and fathers, aiding in reducing postpartum stress and promoting family bonding.
- Supportive Work Environment: Cultivate a culture that supports mental health, providing resources like Employee Assistance Programs (EAPs) that offer counselling and mental health support, and training managers to recognise and appropriately respond to mental health issues.
- Childcare Support: Ease one of the significant stresses for working parents by assisting with childcare, whether through onsite facilities, partnerships with local childcare providers, or subsidies.
- Health and Wellness Programs: Promote overall health and well-being through programs that include stress management workshops, wellness apps, and access to fitness centres, all of which can improve mental health.
Final Thoughts
Maternal Mental Health Awareness Week serves as a vital reminder of the unique mental health challenges mothers face during one of the most transformative phases of their lives. By understanding and addressing these issues, we can contribute to healthier families and stronger communities. Our active support can profoundly impact the lives of countless women returning to the workforce.
For more information on maintaining good mental health during pregnancy, visit the NHS’s Mental Health in Pregnancy page. If you think a referral might help, please speak to your midwife, GP, health visitor, social worker, mental health service, or a support charity.
Latest Stories
Women’s Health Internship
Nurturing Future Women’s Health Leaders
Olivia Bosworth’s internship journey at LPC.
-
Published
-
Last Modified
Tags
Meet Olivia, a dedicated Global Health major from the U.S., interning at the London Pregnancy Clinic (LPC) as she journeys towards becoming a Maternal Fetal Medicine physician. Discover the invaluable experiences she’s gained and the profound impact of her work.
Embarking on a journey from the U.S. to London, Olivia’s story at the London Pregnancy Clinic is one of growth, discovery, and commitment to maternal health. This blog delves into how her internship at LPC has been pivotal in her pursuit of a career in Maternal Fetal Medicine, providing her with unparalleled insights into the dynamics of prenatal care.
Immersion in London’s Medical Community
“I immediately knew it would be the perfect fit,” Olivia reflects. Her year abroad is dedicated to soaking up every element of British healthcare, with LPC serving as a comprehensive backdrop. This chance to juxtapose various healthcare practices has been incredibly beneficial, broadening her perspective for her future medical career.
Multifaceted Role in Prenatal Care
Olivia’s daily duties at LPC are diverse and impactful. As part of the medical assistant team, she’s pivotal in the clinic’s day-to-day operations, often starting her day at reception, assisting with patient check-ins and administrative tasks.
Her role extends beyond these duties; Olivia collaborates closely with a wide range of women’s health specialists, including gynaecologists, obstetricians, and early pregnancy scan specialists. This collaboration has enriched her understanding of prenatal care comprehensively.
These interactions allow Olivia to witness the interdisciplinary nature of women’s healthcare firsthand. She assists in clinical settings, engages in patient care planning discussions, and observes intricate medical procedures. Exposure to various specialities not only boosts her medical knowledge but also deepens her appreciation for the collaborative efforts needed to deliver top-notch prenatal care.
In addition to her administrative responsibilities, Olivia enhances LPC’s digital outreach. She contributes to the LPC YouTube channel, aiming to educate and inform a global audience about pregnancy. Here, she hosts videos discussing topics like pregnancy trimesters and LPC’s pregnancy scan timeline.
Lessons in Compassion and Professionalism
LPC’s approach to handling sensitive situations profoundly impacts Olivia. Observing the staff’s compassionate delivery of difficult news has underscored the importance of empathy in healthcare. These experiences have shaped her professional and personal growth significantly.
Olivia’s Internship experience
Every day presents new challenges and learning opportunities, fuelling Olivia’s passion for maternal-fetal medicine. “I’ve gained extensive knowledge in prenatal care, especially in recognising the significant impact of consistent sonography throughout pregnancy,” she comments. Olivia’s narrative powerfully illustrates how crucial hands-on experience is for those committed to making a healthcare impact.
She adds, “Seeing the joy of expectant mothers upon receiving positive Non-invasive Prenatal Testing (NIPT) results or viewing a 3D scan of their baby is both captivating and heartwarming.”
Watch Olivia’s full interview below.
Building a Foundation for Excellence in Women’s Health
At LPC, we’re dedicated to training the next wave of healthcare professionals, with a focus on prenatal care. Our internship program not only provides practical experience but also fosters future field leaders. Our interns inject fresh perspectives and energy into our clinic, crucial for our ongoing improvement and innovation.
Final Thoughts
Olivia’s internship at LPC is more than just a career step; it’s a leap towards making a real difference in family lives. Her experiences highlight the value of LPC’s internship program in shaping healthcare’s future leaders.
We ensure our interns engage in all clinic aspects, from patient care to community outreach via our digital platforms. This comprehensive approach equips them for future healthcare challenges and opportunities, providing the necessary skills to excel in any medical setting.
Inspired by Olivia’s journey? Keen to contribute to pioneering prenatal care? Visit our careers page to learn more about LPC’s internship opportunities and how you can join a team that champions growth, compassion, and excellence in healthcare.
Latest Stories
- 1
- 2
